Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Central nervous system lymphoma associated with natalizumab.
The refinement of genetic predictors of multiple sclerosis.
Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis.
Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study.
Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
Video game training enhances cognitive control in older adults.
The impact of multiple sclerosis on family members: a review of the literature.
Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis.
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
Human Endogenous Retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Modeling the heterogeneity of multiple sclerosis in animals.
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
FDA approves first oral drug to reduce MS relapses
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Ozone: a multifaceted molecule with unexpected therapeutic activity.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study.
In vivo vs. ex vivo Magnetic Resonance Imaging In Mice.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.

Pages